Protein kinase C in normal and pathologic myocardial states

Journal of Surgical Research

Volumn 81, Issue 2, 1999, Pages 249-259

  Cain, Brian S ^a   Meldrum, Daniel R ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Adenosine; Cardiac bypass; Contraction; cPKC; Human; Infarction; Inflammation; Ischemia reperfusion; Ischemic preconditioning; Isoforms; nPKC; Preconditioning; Rat; Sepsis; TNF ; Translocation

Indexed keywords

CALCIUM ION; CYTOKINE; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ENZYME ACTIVITY; HEART CONTRACTION; HEART MUSCLE; HEART MUSCLE REPERFUSION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033079970     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5508     Document Type: Review

References (166)

1. Mochly-Rosen, D. Localization of protein kinases by anchoring proteins: A theme in signal transduction. Science 268: 247, 1995.
2. Nishizuka, Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607, 1992.
3. 2+ sensitivity in intact and skinned muscles from normal and diseased human myocardium. Circ. Res. 67: 744, 1990.
4. Dosemeci, A., Dhallen, R. S., Cohen, N. M., Lederer, W. J., and Rogers, T. B. Phorbol ester increases calcium current and stimulates the effects of angiotensin II on cultured neonatal rat heart myocytes. Circ. Res. 62: 347, 1988.
5. Pucéat, M., Clément-Chomienne, O., Terzic, A., and Vassort, G. Alpha-adrenoceptor and purinoceptor agonists modulate Na-H antiport in single cardiac cells. Am. J. Physiol. 264: H310, 1993.
6. Venema, R., and Kuo, J. Protein kinase C-mediated phosphorylation of troponin I and C-protein in isolated myocardial cells is associated with inhibition of myofibrillar actomyosin MgATPase. J. Biol. Chem. 268: 2705, 1993.
7. 2+ induced cardioadaptation to ischemia-reperfusion injury. Am. J. Physiol. 271: R1718, 1996.
8. Meldrum, D. R., Cleveland, J. C., Sheridan, B. C., Rowland, R. T., Banerjee, A., and Harken, A. H. Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann. Thorac. Surg. 61: 1273, 1996.
9. i. J. Mol. Cell. Cardiol. 24: 937, 1992.
10. Mitchell, M. B., Meng, X., Parker, C. G., Brown, J. M., Harken, A. H., and Banerjee, A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ. Res. 76: 73, 1995.
11. + channel? Circ. Res. 77: 1030, 1995.
12. Erdbrugger, W., Keffel, J., Knocks, M., Otto, T., Philipp, T., and Michel, M. C. Protein kinase C isoenzymes in rat and human myocardial tissues. Br. J. Pharmacol. 120: 177, 1997.
13. Meldrum, D. R., Cleveland, J. C., Sheridan, B. C., Rowland, R. T., Banerjee, A., and Harken, A. H. Calcium induced inotropy is in part mediated by protein kinase C. J. Surg. Res. 400, 1996.
14. Cain, B. S., Meldrum, D. R., Cleveland, J. C., Meng, X., Banerjee, A., and Harken, A. H. The alpha and beta isoforms of protein kinase C mediate the human myocardial contractile response to exogenous calcium. Surg. Forum XLVIII: 335, 1997.
15. 2+ in isolated mammalian ventricular myocytes. J. Physiol. (London) 444: 481, 1991.
16. Venema, R., Raynor, R., Noland, T., and Kuo, J. Role of protein kinase C in the phosphorylation of cardiac myosin light chain 2. Biochem. J. 294: 401, 1993.
17. Bit, R. A., Davis, P. D., Elliot, L. H., Harris, W., Hill, C. H., Keech, E., Kumat, H., Lawton, G., Maw, A., and Nixon, J. S. Inhibitors of protein kinase C: 3 Potent and highly selective bisindolylmaleimaides by conformational restriction. J. Med. Chem. 36: 21, 1993.
18. Martiny-Baron, G., Kazanietz, M. G., Mischak, H., Blumberg, P. M., Kochs, G., Hug, H., Marme, D., and Schachtele, C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268: 9194, 1993.
19. Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., and Loriolle, F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266: 15771, 1991.
20. Qatsha, K. A., Rudolph, C., Marme, D., Schachtele, C., and May, W. S. Go 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro. Proc. Natl. Acad. Sci. USA 90: 4674, 1993.
21. Deng, X. F., Mulay, S., and Varma, D. R. Role of Ca(2+)-independent PKC in alpha 1-adrenoceptor-mediated inotropic responses of neonatal rat hearts. Am. J. Physiol. 273: H1113, 1997.
22. Meldrum, D. R., Meng, X., Sheridan, B. C., McIntyre, R. C., Harken, A. H., and Banerjee, A. Tissue-specific protein kinase C isoforms differentially mediate macrophage TNFα and IL-1β production. Shock 9: 256, 1998.
23. Banerjee, A., Gamboni-Robertson, F., Mitchell, M. B., Rehring, T. F., Butler, K., Cleveland, J. C., Meldrum, D. R., Shapiro, J. I., and Meng, X. Stress induced cardioadaptation reveals a code linking hormone receptors and spatial redistribution of PKC isoforms. Ann. N.Y. Acad. Sci. 793: 226, 1996.
24. Karmazyn, M., Watson, J. E., and Moffat, M. P. Mechanisms for cardiac depression induced by phorbol myristate acetate in working rat hearts. Br. J. Pharmacol. 100: 826, 1990.
25. i in isolated perfused rat hearts. Am. Heart J. 122: 786, 1991.
26. Lasley, R. D., Noble, M. A., Paulsen, K. L., and Mentzer, R. M. Adenosine attenuates phorbol ester-induced negative inotropic and vasoconstrictive effects in rat hearts. Am. J. Physiol. 266: H2159, 1994.
27. Pi, Y., Sreekumar, R., Huang, X., and Walker, J. W. Positive inotropy mediated by diacylglycerol in rat ventricular myocytes. Circ. Res. 81: 92, 1997.
28. Teutsch, I., Weible, A., and Siess, M. Differential inotropic and chronotropic effects of various protein kinase C activators on isolated guinea pig atria. Eur. J. Pharmacol. 144: 363, 1987.
29. Karmazyn, M., and Haist, J. V. Calcium dependent positive inotropic effects of low phorbol ester concentrations in isolated rat hearts. Cardiovasc. Res. 27: 390, 1993.
30. Leatherman, G. F., Kim, D., and Smith, T. W. Effects of phorbol esters on contractile state and calcium flux in cultured chick heart cells. Am. J. Physiol. 252: H205, 1987.
31. Mckenna, T. M., Li, S., and Tao, S. PKC mediates LPS- and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility. Am. J. Physiol. 269: H1891, 1995.
32. 2+ in adult rat myocytes. Circ. Res. 66: 1143, 1990.
33. 2+ channels. Nature (London) 335: 249, 1988.
34. Cleveland, J. C., Wollmering, M. M., Meldrum, D. R., Rowland, R. T., Rehring, T. F., Sheridan, B. C., Harken, A. H., and Banerjee, A. Ischemic preconditioning in human and rat ventricle. Am. J. Physiol. 271: H1786, 1996.
35. Banerjee, A., Winter-Locke, C., Rogers, K., Mitchell, M., Brew, E., Carins, C., Bensard, D. D., and Harken, A. H. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha-1 adrenergic mechanism. Circ. Res. 73: 656, 1993.
36. Murry, C. E., Jennings, R. B., and Reimer, K. A. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124, 1986.
37. Yellon, D. M., Alkhulaifi, A. M., and Pugsley, W. B. Preconditioning the human myocardium. Lancet 342: 276, 1993.
38. Walker, D. M., Walker, J. M., Pugsley, W. B., Pattison, C. W., and Yellon, D. M. Preconditioning in isolated superfused human muscle. J. Mol. Cell. Cardiol. 27: 1349, 1995.
39. Grosso, M. A., Brown, J. M., Muluin, D., Velasco, S. E., Repine, J. E., and Harken, A. H. Xanthine oxidase derived oxygen radicals induce pulmonary edema via direct endothelial cell injury. J. Surg. Res. 46: 355, 1989.
40. Cain, B. S., and Harken, A. H. Surgical treatment of diastolic dysfunction. J. Card. Surg. 12: 238, 1997.
41. Cain, B. S., Meldrum, D. R., Joo, K. S., Davis, R. J., and Harken, A. H. Diastolic hibernation masquerading as constrictive pericarditis. J. Card. Surg. 12: 235, 1997.
42. Cain, B. S., Meldrum, D. R., Joo, K. S., Wang, J. F., Meng, X., Cleveland, J. C., Banerjee, A., and Harken, A. H. Human SERCA2a levels correlate inversely with age in senescent human myocardium. J. Am. Coll. Cardiol. 32: 458, 1998.
43. Steenbergen, C., Fralix, T. A., and Murphy, E. Role of increased cytosolic free calcium concentration in myocardial ischemic injury. Basic Res. Cardiol. 88: 456, 1993.
44. Shen, A. C., and Jennings, R. B. Myocardial calcium and magnesium in acute ischemic injury. Am. J. Pathol. 67: 417, 1972.
45. 2+, 1983.
46. Meldrum, D. R., Mitchell, M. B., Banerjee, A., and Harken, A. H. Cardiac preconditioning: Induction of endogenous tolerance to ischemia-reperfusion injury. Arch. Surg. 128: 1208, 1993.
47. Meldrum, D. R. Mechanisms of cardiac preconditioning: Ten years after the discovery of ischemic preconditioning. J. Surg. Res. 73: 1, 1998.
48. Kloner, R., Shook, T., Przyklenk, K., Davis, V., Junio, L., Matthews, R., Burstein, S., Gibson, C., Poole, W., Cannon, C., McCabe, C., and Braunwald, E. Previous angina alters inhospital outcome in TIMI 4 a clinical correlate to preconditioning? Circulation 91: 37, 1995.
49. Deanfield, J. E., Maseri, A., Selwyn, A. P., Ribeiro, P., Chierchia, S., Krikler, S., and Morgan, M. Myocardial ischaemia during daily life in patients with stable angina: Its relation to symptoms and heart rate changes. Lancet 2: 753, 1983.
50. Deutsch, E., Berger, M., Kussmaul, W., Hirshfeld, J., Herrmann, H., and Laskey, W. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: Clinical, hemodynamic, and metabolic features. Circulation 82: 2044, 1990.
51. Meissner, G., and Henderson, J. Rapid calcium release from cardiac sarcoplasmic reticulum vesicles is dependent on Ca+2 and is modulated by Mg+2, adenine nucleotide, and calmodulin. J. Biol. Chem. 262: 3065, 1987.
52. Meldrum, D. R., Cleveland, J. C., Sheridan, B. C., Rowland, R. T., Banerjee, A., and Harken, A. H. Differential effects of adenosine preconditioning on the postischemic rat myocardium. J. Surg. Res. 65: 159, 1996.
53. Meldrum, D. R., Cleveland, J. C., Meng, X., Sheridan, B. C., Gamboni, F., Cain, B. S., Harken, A. H., and Banerjee, A. Protein kinase C isoform diversity in preconditioning. J. Surg. Res. 69: 183, 1997.
54. Meldrum, D. R., Cleveland, J. C., Rowland, R. T., Banerjee, A., Harken, A. H., and Meng, X. Early and delayed preconditioning: Differential mechanisms and additive protection. Am. J. Physiol. 273: H725, 1997.
55. Meldrum, D. R., Cain, B. S., Cleveland, J. C., Meng, X., Ayala, A., and Harken, A. H. Adenosine decreases post-ischemic myocardial TNFα: Implications for preconditioning and transplantation. Immunology 92: 472, 1997.
56. + channel. J. Mol. Cell. Cardiol. 29: 175, 1997.
57. Cain, B. S., Meldrum, D. R., Meng, X., Pulido, E. J., Banerjee, A., and Harken, A. H. Therapeutic anti-dysrhythmic and functional protection in human atria. J. Surg. Res. 76: 143, 1998.
58. Cain, B. S., Meldrum, D. R., Dinarello, C. A., Meng, X., Banerjee, A., and Harken, A. H. Adenosine reduces cardiac TNF-α production and human myocardial injury following ischemia-reperfusion. J. Surg. Res. 76: 117, 1998.
59. 1-adrenoceptors. Am. J. Physiol. 273: H902, 1997.
60. Meldrum, D. R., Cleveland, J. C., Sheridan, B. C., Rowland, R. T., Banerjee, A., and Harken, A. H. Cardiac preconditioning with calcium: Clinically accessible myocardial protection. J. Thorac. Cardiovasc. Surg. 112: 778, 1996.
61. Ashraf, M., Suleiman, J., and Ahmad, M. Calcium preconditioning elicits a unique protection against the calcium paradox injury in rat heart: Role of adenosine. Circ. Res. 74: 360, 1994.
62. Miyawaki, H., Zhou, X., and Ashraf, M. Calcium preconditioning elicits strong protection against ischemic injury via protein kinase C signaling pathway. Circ. Res. 79: 137, 1996.
63. Cain, B. S., Meldrum, D. R., Meng, X., Shames, B. D., Banerjee, A., and Harken, A. H. Calcium preconditioning in human myocardium. Ann. Thorac. Surg. 65: 1065, 1998.
64. Cleveland, J. C., Meldrum, D. R., Rowland, R. T., Sheridan, B. C., Banerjee, A., and Harken, A. H. The obligate role of protein kinase C in mediating clinically accessible cardiac preconditioning. Surgery 120: 345, 1996.
65. Cleveland, J. C., Meldrum, D. R., Cain, B. S., Banerjee, A., and Harken, A. H. Oral sulfonylurea agents prevent ischemic preconditioning in human myocardium. Circulation 96: 29, 1997.
66. Cleveland, J. C., Meldrum, D. R., Rowland, R. T., Banerjee, A., and Harken, A. H. Adenosine preconditioning of human myocardium is mediated through KATP channel activation. Surg. Forum XLVII: 209, 1996.
67. Meldrum, D. R., Cleveland, J. C., Mitchell, M. B., Rowland, R. T., Banerjee, A., and Harken, A. H. Constructive priming of myocardium against ischemia-reperfusion injury. Shock 6: 238, 1996.
68. 2+ as a mediator of ischemic preconditioning. Circ. Res. 80: 790, 1997.
69. Miyawaki, H., and Ashraf, M. Isoproterenol mimics calcium preconditioning-induced protection against ischemia. Am. J. Physiol. 272: H927, 1997.
70. 2+ in activation of protein kinase C during ischemic preconditioning. Circulation 96: 1257, 1997.
71. Przyklenk, K., Hata, K., and Kloner, R. A. Is calcium a mediator of infarct size reduction with preconditioning in canine myocardium? Circulation 96: 1305, 1997.
72. Kihara, Y., Grossman, W., and Morgan, J. P. Direct measurement of changes in intracellular calcium transients during hypoxia, ischemia, and reperfusion of the intact mammalian heart. Circ. Res. 65: 1029, 1989.
73. Smith, G. B., Stefenelli, T., Wu, S. T., Wilkman-Cofelt, J., Parmely, W. W., and Zaugg, C. E. Rapid adaptation of myocardial calcium homeostasis to short episodes of ischemia in isolated rat hearts. Am. Heart J. 131: 1106, 1996.
74. 2+. Pharmacol. Rev. 40: 87, 1988.
75. Fox, A. C., Reed, G. E., Meilman, H., and Silk, B. B. Release of nucleosides from canine and human hearts as an index of prior ischemia. Am. J. Cardiol. 43: 52, 1979.
76. Vrobel, T. R., Jorgensen, C. R., and Bache, R. J. Myocardial lactate and adenosine metabolite production as indicators of excercise-induced myocardial ischemia in the dog. Circulation 66: 554, 1982.
77. Smolenski, R. T., Simmonds, H. A., and Chambers, D. J. Exogenous adenosine, supplied transiently during reperfusion, ameliorates depressed endogenous adenosine production in the post-ischemic rat heart. J. Mol. Cell. Cardiol. 29: 333, 1997.
78. DeJong, J. W., and VanHeughteon, H. A. A. Signal transduction by the phosphoinositol cycle in myocardium. J. Mol. Cell. Cardiol. 27: 93, 1995.
79. Kitakaze, M., Hori, M., and Kamada, T. Role of adenosine and its interaction with α adrenoceptor in ischaemic and reperfusion injury of the myocardium. Cardiovasc. Res. 27: 18, 1993.
80. Engler, R. L., and Yellon, D. M. Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease: Time for reconsideration. Circulation 94: 2297, 1996.
81. Talosi, L., and Kranias, E. G. Effect of alpha-adrenergic stimulation on activation of protein kinase C and phosphorylation of proteins in intact rabbit hearts. Circ. Res. 70: 670, 1992.
82. Vegh, A., Szekeres, L., and Parrat, J. R. Local intracoronary infusions of bradykinin profoundly reduce the severity of ischemia-induced arrhythmias in anaesthetized dogs. Br. J. Pharmacol. 104: 294, 1991.
83. Vegh, A., Komori, S., Szekeres, L., and Parratt, J. R. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc. Res. 26: 487, 1992.
84. Tosaki, A., Cordis, G. A., Szerdahelyi, P., Engelman, R. M., and Das, D. K. Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals, and ion shifts in isolated ischemic/reperfused rat hearts. J. Cardiovasc. Pharmacol. 23: 365, 1994.
85. Lawson, C. S., Avkiran, M., Shattock, M. J., Coltart, D. J., and Hearse, D. J. Preconditioning and reperfusion arrythmias in the isolated rat heart: True protection or temporal shift in vulnerability? Cardiovasc. Res. 12: 2274, 1993.
86. Hagar, J. M., Hale, S. L., and Kloner, R. A. Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat. Circ. Res. 68: 61, 1991.
87. Arom, K. V., Angaran, D. M., Lindsay, W. G., Northrup, W. F., and Nicoloff, D. M. Effect of sodium nitroprusside during the payback period of cardiopulmonary bypass on the incidence of postoperative arrhythmias. Ann. Thorac. Surg. 34: 307, 1982.
88. Hashimoto, K., Ilstrup, D. M., and Schaff, H. V. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. J. Thorac. Cardiovasc. Surg. 101: 56, 1991.
89. Airaksinen, K. E., and Huikuri, H. V. Antiarrhythmic effect of repeated coronary occlusion during balloon angioplasty. J. Am. Coll. Cardiol. 29: 1035, 1997.
90. Smith, R. C., Leung, J. M., Keith, F. M., Merrick, S., and Mangano, D. T. Ventricular dysrhythmias in patients undergoing coronary artery bypass graft surgery: Incidence, characteristics, and prognostic importance. Study of Perioperative Ischemia (SPI) Research Group. Am. Heart J. 123: 73, 1992.
91. Murohara, Y., Yui, Y., Hattori, R., and Kawai, C. Effects of superoxide dismutase on reperfusion arrhythmias and left ventricular function in patients undergoing thrombolysis for anterior wall acute myocardial infarction. Am. J. Cardiol. 67: 765, 1991.
92. Hohnloser, S. H., Zabel, M., Olschewski, M., Kasper, W., and Just, H. Arrhythmias during the acute phase of reperfusion therapy for acute myocardial infarction: Effects of beta-adrenergic blockade. Am. Heart J. 123: 1530, 1992.
93. Pasceri, V., Lanza, G. A., Patt, G., Pedrotti, P., Crea, F., and Maseri, A. Preconditioning by transient myocardial ischemia confers protection against ischemia-induced ventricular arrhythmias in variant angina. Circulation 94: 1850, 1996.
94. Moreno, F. L., Villanueva, T., Karagounis, L. A., and Anderson, J. L. Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. TEAM-2 Study Investigators. Circulation 90: 94, 1994.
95. Okishige, K., Yamashita, K., Yoshinaga, H., Azegami, K., Satoh, T., Goseki, Y., Fujii, S., Ohira, H., and Satake, S. Electrophysiologic effects of ischemic preconditioning on QT dispersion during coronary angioplasty. J. Am. Coll. Cardiol. 28: 70, 1996.
96. Vegh, A., Papp, J. G., Szekeres, L., and Parratt, J. R. Are ATP sensitive potassium channels involved in the pronounced antiarrhythmic effects of preconditioning? Cardiovasc. Res. 27: 638, 1993.
97. Lu, H., Remeysen, P., and Clerck, F. D. The protection by ischemic preconditioning against myocardial ischemia- and reperfusion-induced arrhythmias is not mediated by ATP-sensitive potassium channels in rats. Coron. Artery Dis. 4: 649, 1993.
98. + currents by protein kinase C and adenosine: Implications for ischemic preconditioning. Circ. Res. 78: 443, 1996.
99. Shapira, L., Sylvia, V. L., Halabi, A., Soskolne, W. A., Dyke, T. E. V., Dean, D. D., Boyan, B. D., and Schwartz, Z. Bacterial lipopolysaccharide induces early and late activation of protein kinase C in inflammatory macrophages by selective activation of PKC-epsilon. Biochem. Biophys. Res. Commun. 240: 629, 1997.
100. West, M. A., LeMieur, T., Clair, L., Bellingham, J., and Rodriguez, J. L. Protein kinase C regulates macrophage tumor necrosis factor secretion: Direct protein kinase C activation restores tumor necrosis factor production in endotoxin tolerance. Surgery 122: 204, 1997.
101. Wyatt, T. A., Ito, H., Veys, T. J., and Spurzem, J. R. Stimulation of protein kinase C activity by tumor necrosis factor-alpha in bovine bronchial epithelial. Am. J. Physiol. 273: L1007, 1997.
102. Kobayashi, D., Watanabe, N., Yamauchi, N., Tsuji, N., Sato, T., Sasaki, H., Okamoto, T., and Niitsu, Y. Protein kinase C inhibitors augment tumor-necrosis-factor-induced apoptosis in normal human diploid cells. Chemotherapy 43: 415, 1997.
103. Sawai, H., Okazaki, T., Takeda, Y., Tashima, M., Sawada, H., Okuma, M., Kishi, S., Umehara, H., and Domae, N. Ceramide-induced translocation of protein kinase C-delta and -epsilon to the cytosol. Implications in apoptosis. J. Biol. Chem. 272: 2452, 1997.
104. Chen, C. C., Liau, C. S., and Lee, Y. T. Tumor necrosis factor-alpha, platelet-activating factor, and hydrogen peroxide activate protein kinase C subtypes alpha and epsilon in human saphenous vein endothelial cells. J. Cardiovasc. Pharmacol. 28: 240, 1996.
105. Levine, S. J., Logun, C., Chopra, D. P., Rhim, J. S., and Shelhamer, J. H. Protein kinase C, interleukin-1 beta, and corticosteroids regulate shedding of the type I, 55 kDa TNF receptor from human airway epithelial cells. Am. J. Respir. Cell. Mol. Biol. 14: 254, 1996.
106. Chabot-Fletcher, M., Breton, J., Lee, J., Young, P., and Griswold, D. E. Interleukin-8 production is regulated by protein kinase C in human keratinocytes. J. Invest. Dermatol. 103: 509, 1994.
107. Kozawa, O., Suzuki, A., Kaida, T., Tokuda, H., and Uematsu, T. Tumor necrosis factor-alpha autoregulates interleukin-6 synthesis via activation of protein kinase C. Function of sphingosine 1-phosphate and phosphatidylcholine-specific phospholipase C. J. Biol. Chem. 272: 25099, 1997.
108. Abraham, E., Bursten, S., Shenkar, R., Allbee, J., Tuder, R., Woodson, P., Guidot, D. M., Rice, G., Singer, J. W., and Repine, J. E. Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice. J. Exp. Med. 181: 569, 1995.
109. Rice, G. C., Brown, P. A., Nelson, R. J., Bianco, J. A., Singer, J. W., and Bursten, S. Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc. Natl. Acad. Sci. USA 91: 3857, 1994.
110. Rice, G. C., Rosen, J., Weeks, R., Michnick, J., Bursten, S., Bianco, J. A., and Singer, J. W. CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo. Shock 1: 254, 1994.
111. Sando, J. J., and Chertihin, O. I. Activation of protein kinase C by lysophosphatidic acid: Dependence on composition of phospholipid vesicles. Biochem. J. 317: 583, 1996.
112. Jacobson, P. B., Kuchera, S. L., Metz, A., Schachtele, C., Imre, K., and Schrier, D. J. Anti-inflammatory properties of Go 6850: A selective inhibitor of protein kinase C. J. Pharmacol. Exp. Ther. 275: 995, 1995.
113. Vernhet, L., Petit, J. Y., and Lang, F. An anti-inflammatory benzamide derivative inhibits the protein kinase C (PKC)-dependent pathway of ERK2 phosphorylation in murine macrophages. J. Pharmacol. Exp. Ther. 283: 358, 1997.
114. Marais, R., Light, Y., Mason, C., Paterson, H., Olson, M. F., and Marshall, C. J. Requirement of ras-GTP-Raf complexes for activation of raf-1 by protein kinase C. Science 280: 109, 1998.
115. Das, K. C., and White, C. W. Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C. Biol. Chem. 272: 14914, 1997.
116. Meldrum, D. R. Tumor necrosis factor in the heart. Am. J. Physiol. 274: R577, 1998.
117. Meldrum, D. R., Cleveland, J. C., Cain, B. S., Shames, B. D., Meng, X., Bannerjee, A., and Harken, A. H. Ischemic preconditioning downregulates post-ischemic myocardial tumor necrosis factor-α production: Potential ultimate effector mechanism of preconditioning. Circulation 1998, in press.
118. Meng, X., Ao, L., Brown, J. M., Meldrum, D. R., Sheridan, B. C., Cain, B. S., Banerjee, A., and Harken, A. H. LPS induces late cardiac functional protection against ischemia independent of cardiac and circulating TNFα. Am. J. Physiol. 273: H1894, 1997.
119. Brown, J. M., Anderson, B. O., Repine, J. E., Shanley, P. F., White, C. W., Grosso, M. A., Banerjee, A., Bensard, D. D., and Harken, A. H. Neutrophils contribute to TNF induced myocardial tolerance to ischemia. J. Mol. Cell. Cardiol. 24: 485, 1992.
120. Eddy, L. J., Goeddel, D. V., and Wong, G. H. Tumor necrosis factor-alpha pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury. Biochem. Biophys. Res. Commun. 184: 1056, 1992.
121. Nelson, S. K., Wong, G. H., and McCord, J. M. Leukemia inhibitory factor and tumor necrosis factor induce manganese superoxide dismutase and protect rabbit hearts from reperfusion injury. J. Mol. Cell. Cardiol. 27: 223, 1995.
122. DeBoer, L. W., Strauss, H. W., Kloner, R. A., Rude, R. E., Davis, R. F., Maroko, P. R., and Braunwald, E. Autoradiographic method for measuring the ischemic myocardium at risk: Effects of verapamil on infarct size after experimental coronary artery occlusion. Proc. Natl. Acad. Sci. USA 77: 6119, 1980.
123. Kloner, R. A., and Braunwald, E. Effects of calcium antagonists on infarcting myocardium. Am. J. Cardiol. 59: 84B, 1987.
124. Kloner, R., and Przyklenk, K. Progress in cardioprotection: The role of calcium antagonists. Am. J. Cardiol. 66: 2H, 1990.
125. Ferrari, R., Cargnoni, A., Bernocchi, P., Gaia, G., Benigno, M., Pasini, E., Pedersini, P., and Ceconi, C. Effects of felodipine on the ischemic heart: Insight into the mechanism of cytoprotection. Cardiovasc. Drugs Ther. 10: 425, 1996.
126. Krown, K. A., Page, M. T., Nguyen, C., Zechner, D., Gutierrez, V., Comstock, K. L., Glemotski, C. G., Quinana, P. J. E., and Sabbadini, R. A. Tumor necrosis factor alpha-induced apoptosis in cardiac myoctes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J. Clin. Invest. 98: 2854, 1996.
127. Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., and Dixit, V. M. The receptor for the cytotoxic ligand TRAIL. Science 276: 111, 1997.
128. Weigman, K., Schutze, S., Kampen, E., Himmler, A., Machleidt, T., and Kronke, M. Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J. Biol. Chem. 267: 17997, 1992.
129. Meldrum, D. R., Cleveland, J. C., Cain, B. S., Meng, X., and Harken, A. H. Increased myocardial TNFα in a crystalloid perfused model of cardiac ischemia-reperfusion injury. Ann. Thorac. Surg. 65: 439, 1998.
130. Meldrum, D. R., Dinarello, C. A., Meng, X., Shapiro, L., and Harken, A. H. P38 MAP kinase-mediated myocardial TNFα production contributes to post-ischemic cardiac dysfunction. Circulation 96: I-556, 1997.
131. Squadrito, F., Altavilla, D., Zingarelli, B., Ioculano, M., Calapai, G., Campo, G. M., Miceli, A., and Caputi, A. P. Tumor necrosis factor involvement in ischaemia-reperfusion. Eur. J. Pharmacol. 237: 223, 1993.
132. Chandrasekar, B., Colston, J. T., and Freeman, G. L. Induction of proinflammatory cytokine and antioxidant enzyme gene expression following brief myocardial ischemia. Clin. Exp. Immunol. 108: 346, 1997.
133. Gurevitch, J., Frolkis, I., Yuhas, Y., Paz, Y., Matsa, M., Mohr, R., and Yakirevich, V. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J. Am. Coll. Cardiol. 28: 247, 1996.
134. Herskowitz, A. S., Choi, S., Ansari, A. A., and Wesselingh, S. Cytokine mRNA expression in the postischemic/reperfused myocardium. Am. J. Pathol. 146: 419, 1995.
135. Cain, B. S., Meldrum, D. R., Selzman, C., Sheridan, B. C., Meng, X., Banerjee, A., and Harken, A. H. Surgical implications of vascular endothelial physiology. Surgery 122: 516, 1997.
136. Maury, C. P., and Teppo, A. M. Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction. J. Intern. Med. 225: 333, 1989.
137. Lissoni, P., Pelizzoni, F., Mauri, O., Perego, M., Pittalis, S., and Barni, S. Enhanced secretion of tumour necrosis factor in patients with myocardial infarction. Eur. J. Med. 1: 277, 1992.
138. Basaran, Y., Basaran, M. M., Babacan, K. F., Ener, B., Okay, T., Gok, H., and Ozdemir, M. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology 44: 332, 1993.
139. Latini, R., Bianchi, M., Correale, E., Dinarello, C. A., Fantuzzi, G., Fresco, C., Maggoini, A. P., Mengozzi, M., Romano, S., and Shapiro, L. Cytokines in acute myocardial infarction: Selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin 1 receptor antagonist. J. Cardiovasc. Pharmacol. 23: 1, 1994.
140. Hirschl, M. M., Gwechenberger, M., Binder, T., Binder, M., Graf, S., Stefenelli, T., Rauscha, F., Laggner, A. N., and Sochor, H. Assessment of myocardial injury by serum tumour necrosis factor alpha measurements in acute myocardial infarction. Eur. Heart J. 17: 1852, 1996.
141. Marx, N., Neumann, F. J., Ott, I., Gawaz, M., Koch, W., Pinkau, T., and Schomig, A. Induction of cytokine expression in leukocytes in acute myocardial infarction. J. Am. Coll. Cardiol. 30: 165, 1997.
142. Cleveland, J. C., Meldrum, D. R., Rowland, R. T., Banerjee, A., and Harken, A. H. Optimal myocardial preservation: Cooling, cardioplegia and conditioning. Ann. Thorac. Surg. 61: 760, 1996.
143. Hattler, B. G., Zeevi, A., Oddis, C. V., and Finkel, M. S. Cytokine induction during cardiac bypass: Analysis of TNF-alpha expression pre- and postcardiopulmonary bypass. J. Card. Surg. 10: 418, 1995.
144. Marti, F., Munoz, J., Piero, M., Bertran, E., Ferran, C., Octavio, C., Garcia, J., and Rueda, F. Higher cytotoxic activity and increased levels of IL-1 beta, IL-6, and TNF-alpha in patients undergoing cardiopulmonary bypass. Am. J. Hematol. 49: 237, 1995.
145. Casey, W. F., Hauser, G. J., Hannallah, R. S., Midgley, F. M., and Kahn, W. N. Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit. Care Med. 20: 1090, 1992.
146. Hennein, H. A., Ebba, H., Rodriguez, J. L., Merrick, S. H., Keith, F. M., Bronstein, M. H., Leung, J. M., Mangano, D. T., Greenfield, L. J., and Rankin, J. S. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J. Thorac. Cardiovasc. Surg. 108: 626, 1994.
147. Wan, S., DeSmet, J. M., Barvais, L., Goldstein, M., Vincent, J. L., and LeClerc, J. L. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 112: 806, 1996.
148. teVelthuis, H., Jansen, P. G., Straaten, H. M. O.-v., Sturk, A., Eijsman, L., and Wildevuur, C. R. Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor. J. Thorac. Cardiovasc. Surg. 110: 1663, 1995.
149. Wan, S., Marchant, A., DeSmet, J. M., Antoine, M., Zhang, H., Vachiery, J. L., Goldman, M., Vincent, J. L., and LeClerc, J. L. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 111: 469, 1996.
150. Fyfe, A., Daly, P., Galligan, L., Pirc, L., Feindel, C., and Cardella, C. Coronary sinus sampling of cytokines after heart transplantation: Evidence for macrophage activation and interleukin-4 production within the graft. J. Am. Coll. Cardiol. 21: 171, 1993.
151. Hoffen, E. V., Wichen, D. V., Stuij, I., Jonge, N. D., Klopping, C., Lahpor, J., Den, J. V., Tweel, J., Gmelig-Meyling, F., and Weger, R. D. In situ expression of cytokines in human heart allografts. Am. J. Pathol. 149: 1991, 1996.
152. Azzawi, M., Grant, S. D., Hasleton, P. S., Yonan, N., Campbell, C. S., Deiraniya, A. K., Rahman, A., and Hutchinson, I. V. TNF alpha mRNA and protein in cardiac transplant biopsies: Comparison with serum TNF alpha levels. Cardiovasc. Res. 32: 551, 1996.
153. Deng, M. C., Erren, M., Kammerling, L., Gunther, F., Kerber, S., Fahrenkamp, A., Assmann, G., Breithardt, G., and Scheld, H. H. The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. Transplantation 60: 1118, 1995.
154. Oral, H., Kapadia, S., Nakano, M., Torre-Amione, G., Lee, J., Lee-Jackson, D., Young, J. B., and Mann, D. L. Tumor necrosis factor alpha and the failing human heart. Clin. Cardiol. 8: IV20, 1995.
155. Mann, D. L. Stress activated cytokines and the heart. Cytokine Growth Factor Rev. 7: 341, 1996.
156. Shan, K., Kurrelmeyer, K., Seta, Y., Wang, F., Dibbs, Z., Deswal, A., Lee-Jackson, D., and Mann, D. L. The role of cytokines in disease progression in heart failure. Curr. Opin. Cardiol. 12: 218, 1997.
157. Levine, B., Kalman, J., Mayer, L., Fillit, H., and Packer, M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Eng. J. Med. 323: 236, 1990.
158. McMurray, J., Abdullah, I., Dargie, H. J., and Shapiro, D. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br. Heart J. 66: 356, 1991.
159. Dutka, D. P., Elborn, J. S., Delamere, F., Shale, D. J., and Morris, G. K. Tumour necrosis factor alpha in severe congestive cardiac failure. Br. Heart J. 70: 141, 1993.
160. Lommi, J., Pulkki, K., Koskinen, P., Naveri, H., Leinonen, H., Harkonen, M., and Kupari, M. Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Eur. Heart J. 18: 1620, 1997.
161. Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., and Simmons, R. L. Negative notropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387, 1992.
162. Cain, B. S., Meldrum, D. R., Harken, A. H., and McIntyre, R. C. Physiologic basis for anti-cytokine clinical trials in the treatment of sepsis. J. Am. Coll. Surg. 186: 337, 1998.
163. Kumar, A., Thota, V., Dee, L., Olson, J., Uretz, E., and Parrillo, J. E. Tumor necrosis factor-alpha and interleukin 1-beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J. Exp. Med. 3: 949, 1996.
164. i and contractility in isolated adult rabbit ventricular myocytes. Am. J. Physiol. 271: H1449, 1996.
165. Mathias, S., Dressler, K. A., and Kolesnik, R. N. Characterization of a ceramide-activated protein kinase: Stimulation by tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 88: 10009, 1991.
166. Sabbadini, R. A., Betto, R., Teresi, A., Fachechi-Cassano, G., and Salviati, G. The effects of sphingosine on sarcoplasmic reticulum calcium release. J. Biol. Chem. 267: 15475, 1992.